行情

OPGN

OPGN

OpGen
NASDAQ

实时行情|Nasdaq Last Sale

2.480
-0.090
-3.50%
盘后: 2.500 +0.02 +0.81% 19:22 04/03 EDT
开盘
2.550
昨收
2.570
最高
2.670
最低
2.480
成交量
88.98万
成交额
--
52周最高
15.20
52周最低
0.9200
市值
2,958.70万
市盈率(TTM)
-0.1577
分时
5日
1月
3月
1年
5年

分析师评级

1位分析师的综合评级

买入

免责声明:分析师观点仅供投资者决策参考,不构成任何买卖投资建议。

目标价格预测

分析师预测OPGN价格均价为5.00,最高价位5.00,最低价为5.00。

EPS

OPGN 新闻

更多
  • Edited Transcript of OPGN earnings conference call or presentation 24-Mar-20 8:30pm GMT
  • Thomson Reuters StreetEvents · 1天前
  • The Daily Biotech Pulse: Novartis Scraps Deal To Sell Sandoz Assets, Nevro Pre-Announces Q1 Shortfall, Affimed Granted Orphan Drug Designation
  • Benzinga · 2天前
  • The Daily Biotech Pulse: Novartis Scraps Deal To Sell Sandoz Assets, Nevro Pre-Announces Q1 Shortfall, Affimed Granted Orphan Drug Designation
  • Benzinga · 2天前
  • OpGen and Curetis Successfully Close their Business Combination Transaction
  • GlobeNewswire · 2天前

所属板块

生物技术和医学研究
-0.50%
制药与医学研究
-0.22%

热门股票

代码
价格
涨跌幅

OPGN 简况

OpGen, Inc. (OpGen) is a precision medicine company using molecular diagnostics and informatics to combat infectious disease. The Company is engaged in developing molecular information solutions to combat infectious disease in global healthcare settings, helping to guide clinicians with information about life threatening infections, managing patient outcomes, and the spread of infections caused by multidrug-resistant microorganisms. Its deoxyribonucleic acid (DNA) tests and bioinformatics address the threat of anti-biotic resistance by helping physicians and healthcare providers manage patient care decisions and protect the hospital biome through customized screening and surveillance solutions. It is working to deliver its molecular information solution to a global network of customers and partners. It is also working to provide precise diagnostic information powered by pathogen surveillance data. The Company's high-resolution DNA tests are marketed under the Acuitas trade name.
展开

微牛提供OpGen Inc(NASDAQ-OPGN)的股票价格,实时市场报价,专业分析师评级,深度图表和免费的OPGN股票新闻,以帮助您做出投资决策。